Received: 5 April 2022
Accepted: 8 August 2022
First Online: 18 August 2022
: This study was approved by the Medical Ethics Committee of Affiliated Cancer Hospital of Nanjing Medical University. Animal studies were approved by the Institutional Animal Care and Use Committee of Nanjing Medical University (No. IACUC-2012002). All animal studies were complied with the ARRIVE guidelines and conducted in accordance with the UK Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health Guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978). Experiments involving humans were in accordance with the ethical standards of committee (institution and national) and with The Code of Ethics of the World Medical Association (Declaration of Helsinki). All patients completed written informed consent prior to study entry.
: Not applicable.
: The authors declare that they have no competing interests.